Cyclopharm Limited (ASX:CYC)

Cyclopharm Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	126	176	181	109	153	201
Market Cap Growth	-2.75%	-2.75%	66.37%	-28.90%	-23.69%	117.38%
Enterprise Value	113	153	167	87	126	197
Last Close Price	1.13	1.58	1.93	1.16	1.62	2.46
Forward PE	188.94	-	-	-	-	171.49
PS Ratio	4.55	6.39	6.88	4.38	7.66	11.35
PB Ratio	2.94	4.12	5.62	2.98	3.56	11.73
P/TBV Ratio	3.34	4.68	6.63	3.41	3.98	15.91
EV/Sales Ratio	4.11	5.54	6.35	3.49	6.31	11.17
EV/FCF Ratio	-8.47	-	-	-	-	-
Debt / Equity Ratio	0.19	0.19	0.13	0.12	0.11	0.28
Asset Turnover	0.51	0.51	0.55	0.47	0.48	0.58
Inventory Turnover	0.83	0.83	1.11	1.08	0.98	1.10
Quick Ratio	2.54	2.54	2.12	3.53	5.04	1.93
Current Ratio	4.00	4.00	3.48	4.65	5.83	2.81
Return on Equity (ROE)	-35.20%	-35.20%	-13.67%	-16.61%	-16.75%	-29.98%
Return on Assets (ROA)	-16.80%	-16.80%	-13.13%	-7.12%	-6.93%	-11.27%
Return on Capital (ROIC)	-20.75%	-20.75%	-16.20%	-8.48%	-8.39%	-13.72%
Earnings Yield	-10.51%	-7.49%	-2.60%	-6.07%	-3.29%	-3.01%
FCF Yield	-10.65%	-7.60%	-4.10%	-7.29%	-1.61%	-4.55%
Dividend Yield	-	-	0.26%	0.86%	0.62%	0.41%
Buyback Yield / Dilution	-11.05%	-11.05%	-0.53%	-2.77%	-17.10%	-12.43%
Total Shareholder Return	-11.05%	-11.05%	-0.27%	-1.92%	-16.49%	-12.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.